# Luminary Therapeutics, Inc.: funding, NIH (2025)

Registers read on November 19, 2026.

Luminary Therapeutics, Inc. (Minnesota) appears in 2 public registers SpecStream reads: 8 Form D filings and 4 NIH and NSF awards; the newest record is dated November 5, 2025, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 2
- Newest record: November 5, 2025
- State: Minnesota

## Form D filings (SEC)

8 Form D filings, newest November 5, 2025.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/luminary-therapeutics-inc-1793860) | November 5, 2025 | $1.4 million sold of $12.4 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1793860/000143774925033325/0001437749-25-033325-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/luminary-therapeutics-inc-1793860) | January 8, 2025 | $5.2 million sold of $5.9 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1793860/000143774925000739/0001437749-25-000739-index.htm) |
| [Form D amendment](https://specstream.ai/data/form-d/company/luminary-therapeutics-inc-1793860) | January 8, 2025 | $5.2 million sold of $5.5 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1793860/000143774925000736/0001437749-25-000736-index.htm) |
| [Form D amendment](https://specstream.ai/data/form-d/company/luminary-therapeutics-inc-1793860) | August 3, 2023 | $2.4 million sold of $3.5 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1793860/000143774923021823/0001437749-23-021823-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/luminary-therapeutics-inc-1793860) | January 11, 2023 | $2.2 million sold of $2.8 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1793860/000143774923000883/0001437749-23-000883-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/luminary-therapeutics-inc-1793860) | November 4, 2021 | $375 thousand sold of $1.5 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1793860/000143774921025255/0001437749-21-025255-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/luminary-therapeutics-inc-1793860) | February 9, 2021 | $825 thousand sold of $1 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1793860/000143774921002282/0001437749-21-002282-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/luminary-therapeutics-inc-1793860) | November 14, 2019 | $1.5 million sold of $1.5 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1793860/000143774919022844/0001437749-19-022844-index.htm) |

- [Luminary Therapeutics, Inc.](https://specstream.ai/data/form-d/company/luminary-therapeutics-inc-1793860)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1793860&type=D)

## NIH and NSF research awards

4 NIH and NSF awards, newest September 13, 2024.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [NIH](https://specstream.ai/data/research-funding/organization/luminary-therapeutics-inc-mnkbaezhwjs1) | September 13, 2024 | An allogeneic gamma/delta armored Dual-Targeting CAR with Split Costimulatory Domains to Target Epithelial Ovarian Carcinoma; $399.3 | [reporter.nih.gov](https://reporter.nih.gov/project-details/10921643) |
| [NIH](https://specstream.ai/data/research-funding/organization/luminary-therapeutics-inc-mnkbaezhwjs1) | August 1, 2023 | Allogeneic BAFF Ligand Based CAR T-Cells as a Novel Therapy for Systemic Lupus Erythematous; $299.8 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10761003) |
| [NIH](https://specstream.ai/data/research-funding/organization/luminary-therapeutics-inc-mnkbaezhwjs1) | July 1, 2023 | Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies; $1.9 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/11379617) |
| [NIH](https://specstream.ai/data/research-funding/organization/luminary-therapeutics-inc-mnkbaezhwjs1) | August 1, 2021 | Simultaneous Targeting of Tumor and Stroma Cells to Enhance Solid Tumor CAR-T Cell Therapy; $399.7 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10156815) |

- [Luminary Therapeutics, Inc.](https://specstream.ai/data/research-funding/organization/luminary-therapeutics-inc-mnkbaezhwjs1)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (Minnesota), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Minnesota

- [Machinery and tool manufacturers in Minnesota, United States](https://specstream.ai/data/businesses/machinery-and-tool-manufacturers/minnesota-united-states)
- [Internet marketing agencies in Minnesota, United States](https://specstream.ai/data/businesses/internet-marketing-agencies/minnesota-united-states)
- [Graphic design firms in Minnesota, United States](https://specstream.ai/data/businesses/graphic-design-firms/minnesota-united-states)
- [Estate planning law firms in Minnesota, United States](https://specstream.ai/data/businesses/estate-planning-law-firms/minnesota-united-states)
- [Distilleries in Minnesota, United States](https://specstream.ai/data/businesses/distilleries/minnesota-united-states)
- [Coffee shops in Minnesota, United States](https://specstream.ai/data/businesses/coffee-shops/minnesota-united-states)
